About RepRephinehine
RepRephinehine is a Healthcare company based in Stevenage (United Kingdom) founded in 1998, and was acquired by Kester Capital in October 2021. Clinical and regulatory consulting services are provided to pharmaceutical clients. RepRephinehine has completed 1 acquisition, including Rephine. Its chief executive, as recorded, is Rino Coladangelo. Its focus areas include Biopharma Outsourcing, Consulting and Diversified. Its legal entity is REPHINE LIMITED. Its competitors include Clinigen, Fishawack and Science Group; 1 of its 3 listed competitors has raised funding.
Company details
RepRephinehine was founded in 1998 in Stevenage, United Kingdom, as a provider of clinical and regulatory consulting services within the pharmaceutical and biotechnology sectors. Operations are centered in the UK, where expertise in clinical trial management, regulatory compliance, and strategic advisory is offered to support drug development and market access. Services are delivered to clients across Europe and beyond, with leadership provided by CEO Rino Coladangelo.
- Headquarters Stevenage, United Kingdom
- Stage Acquired
- SectorsHealthcare
- Website category Health · Biotechnology and Pharmaceuticals
- Email••••••••
- Phone•••• ••••
- Website rephine.com
- Social LinkedIn X
- Acquired by Kester Capital (Oct 2021)
- Legal Name Rephine Limited
- Date of Incorporation 29 May, 2001
- Jurisdiction STEVENAGE, HERTFORDSHIRE
- Latest Funding Round$58.32K (USD), Grant
Aug 2018
- InvestorsEuropean Union
& 1 more
- Investments & Acquisitions
- Acquired byKester Capital
(Oct 2021)
Funding Insights of RepRephinehine
- Total Rounds 1
- Last Round Grant — $58,318
- First Round $58,318
(Aug 2018)
- Investors Count 1
All 1 funding rounds of RepRephinehine with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2018 | $58,318 | Grant | – | – |
2 investors in total: 2 institutional.
Investors in RepRephinehine
RepRephinehine has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union and Kester Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Kester Capital is focused on private equity investments in technology and life sciences sectors. | kestercapital.com | London, United Kingdom | ||
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for RepRephinehine
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of RepRephinehine
24 people are tracked at RepRephinehine (4 in leadership, 20 in team).
| Name | Role | Group |
|---|---|---|
| CEO | Leadership | |
Atia Bukhari | Marketing Director | Leadership |
Laura Mallo | Audit Operations Director | Leadership |
Pmp® Dr. Mamta Chawla | General Manager | Leadership |
Joseph Neary | Customer Delivery Manager — Americas | Team |
Ignacio Gorozarri | QMS Delivery Consultant | Team |
Rosa Pascual | Planning Manager | Team |
Junaid Kayani | Business Development Manager For UK And Ireland Regions | Team |
Isabel Lemos | GMP Auditor | Team |
Anna Volozhynova | Sales Executive Central And Eastern Europe | Team |
Tania A. | Distribution Department Manager | Team |
Carina Birt | PR For Rephine | Team |
Kiran Robinson | Project Delivery Manager | Team |
Patricia Rodriguez Romero | Audit Technical Manager | Team |
Santosh Padekar | Lead Senior GMP Auditor | Team |
Shruti Menon | CAPA Coordinator | Team |
Sergi Arcas | Pharmaceutical Consultant And Quality Auditor | Team |
Geert A.h. Leroy | Auditor | Team |
Satish Kumar Kothapalli | Planning Coordinator | Team |
Otilia K. | Planning Coordinator | Team |
4 more people are available in the full profile.
Complete people profiles for RepRephinehine
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by RepRephinehine
RepRephinehine has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Rephine.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Rephine is recognized for quality assurance in life sciences. | tdvct.com | Barcelona, Spain | 1997 | Jul 2022 | •••• |
Complete acquisition details for RepRephinehine
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of RepRephinehine
5 dated milestones of RepRephinehine across 24 years, from founding to its latest funding, stage changes and deals.
- Founded RepRephinehine is founded.
- Funding First funding round of $58K.
- Exit Acquired by Kester Capital.
- Acquisition Acquires Rephine.
- Acquisition Acquires Rephine.
Competitors of RepRephinehine
RepRephinehine has 3 listed competitors in our database, 1 of them funded. They include Clinigen, Fishawack and Science Group.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| clinigengroup.com | 2010 | Burton-on-trent, United Kingdom | Specialty medicines are supplied via clinical trials and access programs. | |||
| fishawack.com | 2001 | Brighton, United Kingdom | $23.59M | 45 | Fully integrated cross-border services are delivered to global pharmaceutical organizations. | |
| sciencegroup.com | 1995 | Cambridge, United Kingdom | 431 | Technology-based consultancy and product development services are provided. |
Detailed competitors of RepRephinehine
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of RepRephinehine
The website of RepRephinehine (rephine.com) receives about 6.6K visits a month and ranks #5,666,121 among all websites worldwide, #6,190 in Biotechnology and Pharmaceuticals.
- Monthly visits6.6K
▲ 128.9% vs previous month
- Unique visitors1.2K
per month
- Global rank#5,666,121
among all websites
- Category rank#6,190
Health · Biotechnology and Pharmaceuticals
- Bounce rate38%
- Pages per visit1.8
- Average visit39 sec
- DevicesDesktop 29% · Mobile 71%
Websites whose visitors overlap most with RepRephinehine. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| rcainc.com | 100% | 4.5K | #4,048,405 | View details | |
| instantgmp.com | 97% | 3.4K | #5,178,725 | View details | |
| simplerqms.com | 82% | 57.3K | #652,815 | View details | |
| tevapharm.com | 80% | 166.9K | #278,209 | View details | |
| gmp-navigator.com | 78% | #1,393,505 | View details | ||
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 7 similar websites and full traffic analytics for RepRephinehine
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 7 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Reprephinehine
Complete news archive for RepRephinehine
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about RepRephinehine
RepRephinehine was founded in 1998 and raised its 1st funding round 20 years after it was founded.
RepRephinehine is headquartered in Stevenage, United Kingdom. It is registered at Stevenage, Hertfordshire, United Kingdom.
Rino Coladangelo is the CEO of RepRephinehine, as recorded in our data.
RepRephinehine was founded in 1998 in Stevenage, United Kingdom, as a provider of clinical and regulatory consulting services within the pharmaceutical and biotechnology sectors. Operations are centered in the UK, where expertise in clinical trial management, regulatory compliance, and strategic advisory is offered to support drug development and market access. Services are delivered to clients across Europe and beyond, with leadership provided by CEO Rino Coladangelo.
RepRephinehine's top competitors include Clinigen, Fishawack and Science Group.
RepRephinehine has made 1 acquisition, including Rephine.
RepRephinehine has 2 investors. Key investors include European Union, and Kester Capital.
RepRephinehine operates through Rephine Limited.
Yes. RepRephinehine was acquired by Kester Capital in October 2021.